Jacobs Levy Equity Management Portfolio holdings
Jacobs Levy Equity Management manages U.S. stock portfolios, and its owners Bruce Jacobs and Ken Levy pioneered a research method called disentangling. The firm was founded in 1986, and Jacobs and Levy spent more than three years studying market inefficiencies in U.S. stocks before taking on client money in 1990. Disentangling examines many factors that move stock prices at once, to isolate the separate effect of each, and the firm blends it with behavioral finance theory and human judgment. It runs long-only and long/short portfolios across large and small companies, including versions that hold about 130% or 150% of capital in long positions and 30% or 50% in short ones. Its clients are institutions such as pension plans, endowments, foundations and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$325M |
| 2 |
CrowdStrike
CRWD
|
+$225M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$186M |
| 4 |
Sandisk
SNDK
|
+$155M |
| 5 |
Sysco
SYY
|
+$147M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$418M |
| 2 |
ServiceNow
NOW
|
+$262M |
| 3 |
Apple
AAPL
|
+$260M |
| 4 |
Masco
MAS
|
+$163M |
| 5 |
Roku
ROKU
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.14% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Industrials | 11.2% |
| 5 | Healthcare | 10.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
651
Lands' End
LE
$267M
| $1.48M | 0.01% |
140,793
-17,474
| -11% | -$201K |
2022 Q4
14 quarters
|
|
652
Arrow Electronics
ARW
$9.8B
| $1.47M | 0.01% |
6,876
+973
| +16% | +$194K |
2026 Q1
1 quarter
|
|
653
Treace Medical Concepts
TMCI
$345M
| $1.45M | 0.01% |
363,729
+99,995
| +38% | +$275K |
2026 Q1
1 quarter
|
|
654
Zeta Global
ZETA
$9.36B
| $1.43M | 0.01% |
+72,581
| New | +$1.35M |
2026 Q2
0 quarters
|
|
655
James River Group Holdings
JRVR
$144M
| $1.43M | 0.01% |
324,394
-25,347
| -7% | -$125K |
2019 Q3
27 quarters
|
|
656
Inseego
INSG
$74.5M
| $1.41M | 0.01% |
136,763
+8,597
| +7% | +$115K |
2024 Q4
6 quarters
|
|
657
Crexendo
CXDO
$164M
| $1.41M | 0.01% |
188,899
+110,087
| +140% | +$861K |
2025 Q3
3 quarters
|
|
658
OGE Energy
OGE
$10.7B
| $1.4M | 0.01% |
28,841
| – | – |
2026 Q1
1 quarter
|
|
659
Alta Equipment Group
ALTG
$175M
| $1.4M | 0.01% |
216,739
+95,624
| +79% | +$641K |
2025 Q3
3 quarters
|
|
660
Texas Roadhouse
TXRH
$12.2B
| $1.39M | 0.01% |
7,203
-83,729
| -92% | -$14.3M |
2026 Q1
1 quarter
|
|
661
1stdibs.com
DIBS
$195M
| $1.39M | 0.01% |
283,557
+103,149
| +57% | +$497K |
2023 Q1
13 quarters
|
|
662
Vir Biotechnology
VIR
$1.71B
| $1.39M | 0.01% |
136,335
-1,306,001
| -91% | -$12.4M |
2026 Q1
1 quarter
|
|
663
LifeMD
LFMD
$106M
| $1.39M | 0.01% |
+335,487
| New | +$1.48M |
2026 Q2
0 quarters
|
|
664
Brightstar Lottery PLC
BRSL
$1.77B
| $1.38M | 0.01% |
128,767
| – | – |
2026 Q1
1 quarter
|
|
665
Aldeyra Therapeutics
ALDX
$38.9M
| $1.38M | 0.01% |
646,840
-149,976
| -19% | -$258K |
2025 Q1
5 quarters
|
|
666
People Inc
PPLI
$3.28B
| $1.37M | ﹤0.01% |
29,736
-19,152
| -39% | -$817K |
2025 Q1
5 quarters
|
|
667
Starz Entertainment Corp
STRZ
$447M
| $1.37M | ﹤0.01% |
+47,545
| New | +$1.04M |
2026 Q2
0 quarters
|
|
668
Ribbon Communications
RBBN
$263M
| $1.36M | ﹤0.01% |
582,093
-103,217
| -15% | -$272K |
2019 Q1
29 quarters
|
|
669
Standard BioTools
LAB
$279M
| $1.34M | ﹤0.01% |
+1,633,112
| New | +$1.54M |
2026 Q2
0 quarters
|
|
670
Metropolitan Bank Holding Corp
MCB
$1.18B
| $1.34M | ﹤0.01% |
+13,591
| New | +$1.23M |
2026 Q2
0 quarters
|
|
671
Comstock Resources
CRK
$4.46B
| $1.3M | ﹤0.01% |
87,310
+21,457
| +33% | +$328K |
2025 Q1
5 quarters
|
|
672
Consolidated Edison
ED
$44.9B
| $1.3M | ﹤0.01% |
11,746
-28,808
| -71% | -$3.13M |
2026 Q1
1 quarter
|
|
673
Envela
ELA
$271M
| $1.3M | ﹤0.01% |
+44,935
| New | +$1M |
2026 Q2
0 quarters
|
|
674
Pyxis Oncology
PYXS
$189M
| $1.29M | ﹤0.01% |
428,606
-32,391
| -7% | -$61.9K |
2026 Q1
1 quarter
|
|
675
McGrath RentCorp
MGRC
$3.14B
| $1.28M | ﹤0.01% |
+10,593
| New | +$1.2M |
2026 Q2
0 quarters
|
|
Similar funds
Jacobs Levy Equity Management's Q2 2026 Portfolio in Review
As of Q2 2026, Jacobs Levy Equity Management held 1,111 positions worth $27.8B, up 17% from $23.8B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jacobs Levy Equity Management's Q2 2026 filing shows 158 new, 319 increased, 438 reduced and 177 closed positions. Its largest new stake was Sysco: 1,938,184 shares worth $162M. The largest sale was Qualcomm, an estimated $418M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2026 buy was Sysco: 1,938,184 shares worth $162M.
- Jacobs Levy Equity Management added most to KLA in Q2 2026, an estimated $325M increase.
- Jacobs Levy Equity Management's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $418M.
- Jacobs Levy Equity Management fully exited Roku in Q2 2026, selling an estimated $139M.
- Jacobs Levy Equity Management's ten largest holdings make up 28% of its $27.8B portfolio in Q2 2026.
- Jacobs Levy Equity Management opened 158 new positions and closed 177 in Q2 2026.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $27.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.